Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / A••••••• H••••• M••••

A•••••••• C•••••• P••••••• Announces Investment in A••••••• H••••• M••••

Platform acquisitionannouncedannounced Feb 6, 2007Fact
What happened
Target
A••••••• H••••• M••••
Platform
not an add-on on record
Control
Control
Share acquired
unknown
Industry
unknown
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
3 named
Buy side
  • P•••• M•••••• M••••Deal partnerconfirmed
    ““Over the last decade, regulatory agencies have introduced landmark guidelines and legislation pertaining to the interaction between pharmaceutical companies and healthcare providers,” said P•••• M••••, a Partner at A•••••••• C•••••• P•••••••.”
  • A•••••••• C•••••• P•••••••Sponsorconfirmed
    “A•••••••• C•••••• P••••••• Announces Investment in A••••••• H••••• M•••• | published on A•••••••• C•••••• P•••••••'s own news page arlingtoncap.com”
Side not stated
Evidence
“A•••••••• C•••••• P••••••• Announces Investment in A••••••• H••••• M••••”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 15, 2026
A•••••••• C•••••• P••••••• Announces Investment in A••••••• H••••• M•••• | Private Equity Intelligence | DFX